Literature DB >> 11526104

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

J Wiltfang1, H Esselmann, P Cupers, M Neumann, H Kretzschmar, M Beyermann, D Schleuder, H Jahn, E Rüther, J Kornhuber, W Annaert, B De Strooper, P Saftig.   

Abstract

Urea-based beta-amyloid (Abeta) SDS-polyacrylamide gel electrophoresis and immunoblots were used to analyze the generation of Abeta peptides in conditioned medium from primary mouse neurons and a neuroglioma cell line, as well as in human cerebrospinal fluid. A comparable and highly conserved pattern of Abeta peptides, namely, 1-40/42 and carboxyl-terminal-truncated 1-37, 1-38, and 1-39, was found. Besides Abeta1-42, we also observed a consistent elevation of amino-terminal-truncated Abeta2-42 in a detergent-soluble pool in brains of subjects with Alzheimer's disease. Abeta2-42 was also specifically elevated in cerebrospinal fluid samples of Alzheimer's disease patients. To decipher the contribution of potential different gamma-secretases (presenilins (PSs)) in generating the amino-terminal- and carboxyl-terminal-truncated Abeta peptides, we overexpressed beta-amyloid precursor protein (APP)-trafficking mutants in PS1+/+ and PS1-/- neurons. As compared with APP-WT (primary neurons from control or PS1-deficient mice infected with Semliki Forest virus), PS1-/- neurons and PS1+/+ neurons overexpressing APP-Deltact (a slow-internalizing mutant) show a decrease of all secreted Abeta peptide species, as expected, because this mutant is processed mainly by alpha-secretase. This drop is even more pronounced for the APP-KK construct (APP mutant carrying an endoplasmic reticulum retention motif). Surprisingly, Abeta2-42 is significantly less affected in PS1-/- neurons and in neurons transfected with the endocytosis-deficient APP-Deltact construct. Our data confirm that PS1 is closely involved in the production of Abeta1-40/42 and the carboxyl-terminal-truncated Abeta1-37, Abeta1-38, and Abeta1-39, but the amino-terminal-truncated and carboxyl-terminal-elongated Abeta2-42 seems to be less affected by PS1 deficiency. Moreover, our results indicate that the latter Abeta peptide species could be generated by a beta(Asp/Ala)-secretase activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526104     DOI: 10.1074/jbc.M102790200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.

Authors:  Kina Höglund; Steinar Syversen; Piotr Lewczuk; Anders Wallin; Jens Wiltfang; Kaj Blennow
Journal:  Exp Brain Res       Date:  2005-06-04       Impact factor: 1.972

2.  The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species.

Authors:  Jessica Bien; Tamara Jefferson; Mirsada Causević; Thorsten Jumpertz; Lisa Munter; Gerd Multhaup; Sascha Weggen; Christoph Becker-Pauly; Claus U Pietrzik
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

Review 3.  Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.

Authors:  Franka Scharfenberg; Fred Armbrust; Liana Marengo; Claus Pietrzik; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

4.  Reduced CSF carboxyterminally truncated Abeta peptides in frontotemporal lobe degenerations.

Authors:  M Bibl; B Mollenhauer; S Wolf; H Esselmann; P Lewczuk; J Kornhuber; J Wiltfang
Journal:  J Neural Transm (Vienna)       Date:  2007-01-25       Impact factor: 3.575

5.  Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid.

Authors:  Heinke Schieb; Hartmut Kratzin; Olaf Jahn; Wiebke Möbius; Sabine Rabe; Matthias Staufenbiel; Jens Wiltfang; Hans W Klafki
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

6.  Tyr687 dependent APP endocytosis and Abeta production.

Authors:  Sandra Rebelo; Sandra Isabel Vieira; Hermann Esselmann; Jens Wiltfang; Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

7.  Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

Authors:  Volker Welge; Oliver Fiege; Piotr Lewczuk; Brit Mollenhauer; Hermann Esselmann; Hans-Wolfgang Klafki; Stefanie Wolf; Claudia Trenkwalder; Markus Otto; Johannes Kornhuber; Jens Wiltfang; Mirko Bibl
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

Review 8.  Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?

Authors:  Julie Dunys; Audrey Valverde; Frédéric Checler
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

Review 9.  Neurochemical dementia diagnostics: assays in CSF and blood.

Authors:  Piotr Lewczuk; Joachim Hornegger; Rüdiger Zimmermann; Markus Otto; Jens Wiltfang; Johannes Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

10.  Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes.

Authors:  Philipp Spitzer; Martin Herrmann; Hans-Wolfgang Klafki; Alexander Smirnov; Piotr Lewczuk; Johannes Kornhuber; Jens Wiltfang; Juan Manuel Maler
Journal:  J Neuroinflammation       Date:  2010-10-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.